INVO Fertility, Inc.
IVF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001417926
No open-market purchases or sales by INVO Fertility, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $248.7K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 9
- 13F valueReported value at the end of Q2 2026
- $248.7K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding IVF, Q2 2026
No superinvestor reported holding IVF at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by INVO Fertility, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 (view filing) | Dec 3 | 2 days | Szot Matthew KDirector | SSale | −4 | $1.52 | −$6.08 | −57.1%3 after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Shum SteveChief Executive Officer | PPurchase | +58.9K | $0.95 | +$55.9K | +84.7%128.4K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Ryan BarbaraDirector | PPurchase | +10.5K | $0.95 | +$10.0K | +84.4%23.0K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Davis Trent DDirector | PPurchase | +11.2K | $0.95 | +$10.6K | +49.8%33.6K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Szot Matthew KDirector | PPurchase | +14.5K | $0.95 | +$13.8K | +58.6%39.2K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Segal JeffreyDirector | PPurchase | +9.21K | $0.95 | +$8.75K | +48.5%28.2K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Campbell Michael Jos.Chief Operating Officer | PPurchase | +10.5K | $0.95 | +$10.0K | +16.1%75.8K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Goren AndreaChief Financial Officer | PPurchase | +52.6K | $0.95 | +$50.0K | +68.9%129.0K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Messina RebeccaDirector | PPurchase | +9.87K | $0.95 | +$9.37K | +74.9%23.0K after | |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Doody KevinMedical Director | PPurchase | −177.3K | $0.95 | −$168.4K | −100.0%0 after |
Top 10 13F holders, Q2 2026
The largest institutional positions in INVO Fertility, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 63,174 | $120.0K | 0.00% | +63,174 | New |
| Scientech Research LLC | 32,338 | $61.4K | 0.05% | +32,338 | New |
| StoneX Group Inc. | 15,702 | $29.8K | 0.00% | +15,702 | New |
| Susquehanna International Group, LLP | 11,463 | $21.8K | 0.00% | +11,463 | New |
| Tower Research Capital LLC (TRC) | 8,155 | $15.5K | 0.00% | +8,155 | New |
| SBI Securities Co., Ltd. | 53 | $101 | 0.00% | +50+1,666.7% | Added |
| Caitong International Asset Management Co., Ltd | 38 | $72 | 0.00% | +38 | New |
| Danske Bank A/S | 1 | $2 | 0.00% | +1 | New |
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |